The lung is the most common site of metastasis from various cancers, and an accurate
diagnosis of pulmonary oligometastasis is now possible with advances in diagnostic tools …

1.72–6.964, P= 0.001, respectively) and OS (HR 1.386; 95% CI: 1.107–1.735, P= 0.004; HR
3.894; 95% CI: 1.065–14.236, P= 0.040, respectively) on univariate analysis. On multivariate …

Local treatment for pulmonary oligometastases (one to five lesions) using metastasectomy
or stereotactic ablative radiotherapy (SABR) was investigated in a cohort that received …

An increasing body of experience suggests that oligometastasis represents a minimal
metastatic state with the potential for cure or prolonged survival in selected patients treated …

1. Schultz DB, Filippi AR, Tharlat J et al. Stereotactic ablative radiotherapy for pulmonary
oligometastases and oligometastatic lung cancer. J Thoracic Oncol 2014; 9: 1426–1433. 2 …

The lung is a common site for metastasis of malignant tumors from other organs. The
metastatic cascade is a complex process that involves a series of events. Tumors can …

Methods This is a descriptive, retrospective and observational study of 20 patients treated
with SABR at the Centro de Radioterapia Dean Funes from July 2017 to March 2021. With 1 …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease …

At the time of diagnosis, 40% of patients with non-small cell lung cancer (NSCLC) and
nearly 70% of patients with small cell lung cancer (SCLC) have advanced metastatic …

The most common denominator between surgical papers is the tentative to demonstrate that
LM may offer a prolonged survival. Moreover, the in deep review of the extensive literature …